Janus Henderson Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.04B | Buy |
16,497,366
+3,907,981
| +31% | +$313M | 0.49% | 36 |
|
|
2025
Q4 | $1.2B | Buy |
12,589,385
+617,515
| +5% | +$60.5M | 0.54% | 34 |
|
|
2025
Q3 | $1.17B | Sell |
11,971,870
-185,845
| -2% | -$19.2M | 0.53% | 32 |
|
|
2025
Q2 | $1.31B | Sell |
12,157,715
-1,832,206
| -13% | -$185M | 0.64% | 24 |
|
|
2025
Q1 | $1.39B | Sell |
13,989,921
-987,895
| -7% | -$99.5M | 0.76% | 15 |
|
|
2024
Q4 | $1.34B | Sell |
14,977,816
-767,295
| -5% | -$67.5M | 0.68% | 18 |
|
|
2024
Q3 | $1.32B | Sell |
15,745,111
-2,571,951
| -14% | -$203M | 0.68% | 20 |
|
|
2024
Q2 | $1.41B | Sell |
18,317,062
-295,142
| -2% | -$21.6M | 0.76% | 19 |
|
|
2024
Q1 | $1.27B | Sell |
18,612,204
-838,413
| -4% | -$53.9M | 0.7% | 20 |
|
|
2023
Q4 | $1.12B | Sell |
19,450,617
-1,107,041
| -5% | -$59.1M | 0.67% | 26 |
|
|
2023
Q3 | $1.09B | Buy |
20,557,658
+688,373
| +3% | +$36.1M | 0.71% | 24 |
|
|
2023
Q2 | $1.07B | Sell |
19,869,285
-1,074,611
| -5% | -$56.1M | 0.67% | 26 |
|
|
2023
Q1 | $1.05B | Sell |
20,943,896
-1,571,085
| -7% | -$74M | 0.69% | 23 |
|
|
2022
Q4 | $1.04B | Sell |
22,514,981
-26,201,811
| -54% | -$1.13B | 0.74% | 24 |
|
|
2022
Q3 | $1.89B | Buy |
48,716,792
+22,671,698
| +87% | +$909M | 0.71% | 23 |
|
|
2022
Q2 | $971M | Sell |
26,045,094
-707,854
| -3% | -$28.8M | 0.67% | 22 |
|
|
2022
Q1 | $1.18B | Sell |
26,752,948
-14,487,434
| -35% | -$628M | 0.57% | 26 |
|
|
2021
Q4 | $1.75B | Sell |
41,240,382
-8,681,123
| -17% | -$365M | 0.73% | 17 |
|
|
2021
Q3 | $2.17B | Sell |
49,921,505
-1,863,770
| -4% | -$82.5M | 0.95% | 10 |
|
|
2021
Q2 | $2.21B | Buy |
51,785,275
+822,650
| +2% | +$34.6M | 0.95% | 11 |
|
|
2021
Q1 | $1.97B | Buy |
50,962,625
+3,033,710
| +6% | +$115M | 0.9% | 12 |
|
|
2020
Q4 | $1.72B | Sell |
47,928,915
-773,627
| -2% | -$27.9M | 0.8% | 17 |
|
|
2020
Q3 | $1.86B | Sell |
48,702,542
-1,968,531
| -4% | -$75.9M | 0.97% | 11 |
|
|
2020
Q2 | $1.78B | Buy |
50,671,073
+8,101,149
| +19% | +$292M | 1% | 11 |
|
|
2020
Q1 | $1.39B | Buy |
42,569,924
+3,789,230
| +10% | +$148M | 0.96% | 11 |
|
|
2019
Q4 | $1.75B | Sell |
38,780,694
-563,989
| -1% | -$23.6M | 0.9% | 11 |
|
|
2019
Q3 | $1.6B | Buy |
39,344,683
+92,452
| +0.2% | +$3.92M | 0.87% | 12 |
|
|
2019
Q2 | $1.69B | Buy |
39,252,231
+1,162,625
| +3% | +$44.7M | 0.92% | 12 |
|
|
2019
Q1 | $1.46B | Sell |
38,089,606
-931,961
| -2% | -$35.6M | 0.81% | 11 |
|
|
2018
Q4 | $1.38B | Sell |
39,021,567
-1,280,033
| -3% | -$46.4M | 0.88% | 11 |
|
|
2018
Q3 | $1.55B | Sell |
40,301,600
-1,437,859
| -3% | -$50.2M | 0.83% | 9 |
|
|
2018
Q2 | $1.36B | Buy |
41,739,459
+273,848
| +0.7% | +$8.26M | 0.78% | 11 |
|
|
2018
Q1 | $1.13B | Buy |
41,465,611
+1,118,576
| +3% | +$30.4M | 0.67% | 16 |
|
|
2017
Q4 | $1B | Buy |
40,347,035
+3,663,896
| +10% | +$101M | 0.61% | 22 |
|
|
2017
Q3 | $1.07B | Sell |
36,683,139
-2,179,460
| -6% | -$60.2M | 0.69% | 17 |
|
|
2017
Q2 | $1.08B | Buy |
38,862,599
+38,690,577
| +22,492% | +$1.03B | 0.73% | 16 |
|
|
2017
Q1 | $4.28M | Sell |
172,022
-4,763
| -3% | -$116K | 0.03% | 377 |
|
|
2016
Q4 | $3.83M | Buy |
176,785
+20,355
| +13% | +$444K | 0.03% | 391 |
|
|
2016
Q3 | $3.72M | Sell |
156,430
-4,948
| -3% | -$118K | 0.03% | 379 |
|
|
2016
Q2 | $3.77M | Buy |
161,378
+14,822
| +10% | +$321K | 0.03% | 364 |
|
|
2016
Q1 | $2.76M | Sell |
146,556
-8,922
| -6% | -$157K | 0.02% | 432 |
|
|
2015
Q4 | $2.87M | Hold |
155,478
| – | – | 0.02% | 421 |
|
|
2015
Q3 | $2.55M | Hold |
155,478
| – | – | 0.02% | 434 |
|
|
2015
Q2 | $2.75M | Sell |
155,478
-20,610
| -12% | -$368K | 0.02% | 448 |
|
|
2015
Q1 | $3.13M | Hold |
176,088
| – | – | 0.02% | 444 |
|
|
2014
Q4 | $2.33M | Hold |
176,088
| – | – | 0.02% | 487 |
|
|
2014
Q3 | $2.08M | Hold |
176,088
| – | – | 0.02% | 418 |
|
|
2014
Q2 | $2.25M | Hold |
176,088
| – | – | 0.02% | 402 |
|
|
2014
Q1 | $2.38M | Buy |
176,088
+4,266
| +2% | +$56K | 0.02% | 395 |
|
|
2013
Q4 | $2.07M | Hold |
171,822
| – | – | 0.02% | 389 |
|
|
2013
Q3 | $2.02M | Hold |
171,822
| – | – | 0.02% | 394 |
|
|
2013
Q2 | $1.61M | Buy |
+171,822
| New | +$1.46M | 0.02% | 419 |
|
Other funds holding BSX
VCM
VPM
Janus Henderson Group's BSX Position: Q1 2026 in Review
Janus Henderson Group increased its Boston Scientific (BSX) stake by 31% in Q1 2026, buying an estimated $313M and bringing the position to 16,497,366 shares worth $1.04B. The position accounts for 0.49% of the portfolio, ranked #36.
Janus Henderson Group first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.21B in Q2 2021. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Janus Henderson Group held 16,497,366 shares of Boston Scientific worth $1.04B as of Q1 2026.
- Janus Henderson Group bought 3,907,981 Boston Scientific shares in Q1 2026, an estimated $313M.
- Boston Scientific made up 0.49% of Janus Henderson Group's portfolio in Q1 2026, its #36 holding.
- Janus Henderson Group first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Janus Henderson Group's Boston Scientific position peaked at $2.21B in Q2 2021.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.